Eczema (Atopic Dermatitis): Treatment Options from Steroid Creams to Biologics and JAK Inhibitors
By Dr Lim Tzyy Huei ( 林子辉医生 ) Consultant Dermatologist | Pantai Hospital Batu Pahat, Johor, Malaysia
Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that causes itching, redness, dryness and sometimes painful cracks or wounds.
For many patients, eczema can be controlled with moisturisers and prescribed creams. However, others continue to experience frequent flare-ups, severe itching or widespread inflammation despite appropriate treatment.
What treatment options are available when steroid creams are not enough? Are biologic injections or newer oral medications suitable for severe eczema?
Eczema treatment has advanced considerably in recent years. Today, several treatment options are available, ranging from topical medications to targeted therapies that control specific inflammatory pathways.
Understanding these options can help patients make informed decisions and develop realistic expectations about long-term eczema management.
1. Understanding Eczema Treatment
Eczema develops through a combination of a weakened skin barrier and an overactive inflammatory response.
Heat, sweating, harsh soaps, fragrances, dry skin and other individual triggers can aggravate inflammation and cause flare-ups.
Treatment generally focuses on three important goals:
Controlling inflammation and relieving itching.
Repairing and maintaining the skin barrier.
Preventing frequent flare-ups and improving quality of life.
The treatment approach depends on eczema severity, the areas affected, previous treatment response and individual medical needs.
For a more detailed explanation of common triggers, read my related article: Why Eczema Keeps Coming Back and How to Manage It Better.
2. First-Line Treatment: Steroid Creams and Moisturisers
For most patients with mild-to-moderate eczema, topical treatment is the first step.
Topical Corticosteroids (Steroid Creams)
Topical corticosteroids help reduce inflammation, redness and itching during active eczema flare-ups.
When used correctly, they are generally safe and effective.
During an active flare-up:
Apply the prescribed steroid cream to inflamed areas, usually once daily or as directed.
Use an adequate amount to cover the affected skin.
Continue until inflammation has settled, often within several days to 1–2 weeks, although some flare-ups require longer treatment.
Avoid using potent steroid creams on the face, eyelids, groin or skin folds unless specifically advised by your dermatologist.
Different areas of the body may require different steroid strengths.
What Happens After Eczema Improves?
Once the inflammation has settled, treatment may be reduced, stopped or changed to a milder anti-inflammatory medication.
For patients with frequently recurring eczema, a proactive maintenance strategy may be recommended.
This involves applying a prescribed anti-inflammatory cream twice weekly to previously affected areas, even when the skin appears clear.
Such maintenance treatment can help reduce future flare-ups.
Not every topical steroid requires gradual tapering. The appropriate treatment duration and maintenance plan should be individualised.
Moisturisers: The Foundation of Eczema Care
Even when eczema appears clear, the skin barrier may remain vulnerable to dryness and irritation.
Regular moisturising is therefore essential.
Recommended measures include:
Apply moisturiser at least twice daily.
Moisturise immediately after bathing.
Choose fragrance-free creams or ointments.
Apply moisturiser to the whole body, not only areas affected by eczema.
Continue daily moisturising even when eczema is well controlled.
Steroid creams control inflammation, while moisturisers help maintain the skin barrier. Both are important for long-term eczema control.
For patients concerned about topical steroid safety, you may also read: Are Steroid Creams Always Harmful?
3. Are There Non-Steroid Creams for Eczema?
Yes. Some patients may benefit from non-steroidal anti-inflammatory creams, particularly when eczema affects sensitive areas or requires longer-term maintenance.
Examples include:
Tacrolimus Ointment
Tacrolimus is a topical calcineurin inhibitor that helps control skin inflammation without causing steroid-related skin thinning.
It may be particularly useful for eczema affecting the face, eyelids, neck and skin folds.
Pimecrolimus Cream
Pimecrolimus is another non-steroidal anti-inflammatory medication that may be suitable for selected patients with mild-to-moderate eczema, especially in sensitive areas.
Both medications may initially cause temporary burning or stinging, which often improves with continued use.
These treatments can also be used intermittently for maintenance in suitable patients.
The choice between steroid and non-steroid creams depends on eczema severity, location, age and treatment response.
4. What If Eczema Remains Severe Despite Cream Treatment?
Some patients continue to experience:
Severe or persistent itching.
Widespread eczema.
Frequent flare-ups despite appropriate topical treatment.
Sleep disturbance.
Painful cracks or repeated skin infections.
Significant effects on work, daily activities or quality of life.
In these situations, systemic treatment may be considered.
Systemic treatments act on inflammatory pathways throughout the body rather than treating only individual patches of eczema.
Several options are available.
Conventional Oral Medications
Methotrexate
Methotrexate is an immunomodulating medication usually taken once weekly.
It helps reduce excessive immune activity and may be considered for patients with persistent moderate-to-severe eczema.
Improvement develops gradually, often over 4–12 weeks.
Regular blood monitoring is required because methotrexate may affect the liver, blood counts and other organs. It must not be used during pregnancy.
Cyclosporin
Cyclosporin is a relatively fast-acting immunosuppressant.
Some patients with severe eczema may experience improvement within 1–2 weeks.
It may be particularly useful when relatively rapid control of severe inflammation is required.
However, cyclosporin requires regular monitoring of blood pressure and kidney function and is often used for shorter-term disease control.
5. Biologic Injections for Moderate-to-Severe Eczema
Biologic therapies are newer treatments that target specific immune pathways responsible for eczema inflammation.
Unlike conventional immunosuppressants, they act more selectively on particular inflammatory signals.
Two important options include:
Dupilumab (Dupixent)
Dupilumab blocks signalling from interleukin-4 (IL-4) and interleukin-13 (IL-13), which are important inflammatory pathways in atopic dermatitis.
It is usually administered by subcutaneous injection every two weeks in adults, following an initial loading dose.
Some patients notice improvement in itching within the first few weeks, while more substantial skin improvement may develop over several months.
Dupilumab may be suitable for longer-term control of moderate-to-severe eczema.
Lebrikizumab
Lebrikizumab specifically targets IL-13, an important inflammatory signal involved in eczema.
Treatment initially involves subcutaneous injections every two weeks. After an adequate response, some patients may continue with injections every four weeks for maintenance.
Like dupilumab, it can help reduce itching, inflammation and eczema severity.
Are Biologic Treatments Safe?
Biologic treatments are generally well tolerated in appropriately selected patients.
Possible side effects include:
Injection-site reactions.
Eye irritation or conjunctivitis.
Other treatment-specific adverse effects.
Patients should discuss their medical history and possible side effects with their dermatologist before starting treatment.
Biologics may provide sustained control, but continued treatment is often necessary to maintain improvement.
6. Oral JAK Inhibitors: Targeted Treatment for Eczema
Janus kinase (JAK) inhibitors are targeted oral medications that block inflammatory signals involved in eczema.
One of their important advantages is the potential for relatively rapid improvement in itching.
Examples include:
Upadacitinib (Rinvoq)
A selective JAK1 inhibitor. Some patients experience noticeable itch relief within the first few days of treatment.
Baricitinib (Olumiant)
A JAK1/JAK2 inhibitor that can help reduce itching and inflammation in suitable patients.
Abrocitinib (Cibinqo)
A selective JAK1 inhibitor that may also provide relatively rapid improvement in itching and eczema severity.These medications are generally taken once daily.
What Are the Risks of JAK Inhibitors?
Although JAK inhibitors can be highly effective, they require careful patient selection.
Potential risks include:
Serious infections, including shingles.
Changes in blood counts, liver enzymes or cholesterol.
Blood clots.
Cardiovascular complications and other serious adverse events in susceptible patients.
Screening for infections, including tuberculosis and hepatitis where appropriate, and regular blood monitoring are generally required.
Age, smoking history, cardiovascular risk factors, previous blood clots and other medical conditions are important when considering these medications.
Not every patient needs to try conventional oral immunosuppressants before being considered for biologics or JAK inhibitors.
Treatment choice should follow individual clinical assessment, medication indications and safety considerations.
7. How Long Does Eczema Treatment Take to Work?
Different treatments work at different speeds.
Treatment | General expectation |
Topical steroid creams | Improvement often begins within several days |
Tacrolimus / Pimecrolimus | Improvement generally develops over days to weeks |
Methotrexate | Often takes 4–12 weeks |
Cyclosporin | Some patients improve within 1–2 weeks |
Dupilumab / Lebrikizumab | Itch may improve within weeks; skin improvement develops over subsequent weeks to months |
Oral JAK inhibitors | Itch improvement may begin within days in some patients |
These timelines are general estimates. Individual responses vary depending on eczema severity, treatment adherence and other factors.
Not every patient will achieve completely clear skin, but meaningful reductions in itching, inflammation, sleep disturbance and flare-up frequency are important treatment outcomes.
8. Can Eczema Treatment Be Reduced or Stopped?
Eczema is a chronic condition, and recurrence is possible even after successful treatment.
For patients with mild eczema, topical anti-inflammatory medication may be reduced or stopped once the flare-up has settled, while regular moisturising continues.
Patients with frequently recurring eczema may benefit from intermittent maintenance treatment.
For those receiving biologics, JAK inhibitors or conventional systemic medications, treatment duration depends on disease control, safety and individual response.
Stopping systemic treatment may lead to recurrence in some patients. Therefore, treatment should not be discontinued or adjusted without discussing a suitable plan with the treating dermatologist.
The aim of long-term eczema management is to maintain good disease control using the safest effective treatment strategy.
9. When Should You See a Dermatologist?
Consider consulting a dermatologist if:
Eczema remains uncontrolled despite prescribed creams and moisturisers.
Itching significantly affects sleep or daily activities.
Large areas of the body are affected.
Flare-ups occur frequently or require repeated courses of potent steroid creams.
Painful cracks, wounds or recurrent skin infections develop.
You wish to understand whether biologic injections or oral targeted treatments may be suitable.
A dermatologist can assess eczema severity, review previous treatment responses and recommend an appropriate long-term management plan.
Conclusion: Choosing the Right Eczema Treatment
Eczema treatment is not limited to steroid creams.
For many patients, regular moisturising and appropriate topical anti-inflammatory treatment are sufficient to maintain good control.
For others with moderate-to-severe or frequently recurring eczema, additional options such as methotrexate, cyclosporin, biologic injections or oral JAK inhibitors may provide significant improvement.
Each treatment has different benefits, expected response times and safety considerations.
The most appropriate treatment depends on the patient's eczema severity, age, medical history, previous treatment response and individual needs.
Successful eczema treatment is not simply about clearing the rash temporarily. It is about achieving sustained control, reducing itching and flare-ups, and improving quality of life.
Related Reading
For patients who would like to understand more about eczema and its long-term management:
Why Eczema Keeps Coming Back and How to Manage It Better — Common triggers, skin barrier dysfunction and prevention of recurrence.
Eczema Treatment Explained: Answers to Common Questions and Concerns — Why treatments sometimes change, concerns about stronger creams and the importance of follow-up.
Are Steroid Creams Always Harmful? — Understanding topical steroid safety and common misconceptions.
About the Author
Dr Lim Tzyy Huei (林子辉医生) is a Consultant Dermatologist at Pantai Hospital Batu Pahat, Johor, Malaysia.
His clinical practice includes the diagnosis and treatment of eczema, psoriasis, acne, skin allergies and other inflammatory skin conditions.
He provides individualised treatment plans ranging from topical medication and skin care counselling to conventional systemic therapies, biologic injections and targeted oral treatments for patients with moderate-to-severe eczema.
Disclaimer: This article is intended for general patient education and does not replace individual medical consultation. Treatment availability, approved indications and suitability may vary. Medication benefits, risks and monitoring requirements should be discussed with a qualified healthcare professional.
